Clinical Oncology - Issue Supplementum 1/2022
Article
D. Al Tukmachi, O. Naar, P. Fadrus, V. Vybíhal, O. Slabý, J. Šána
J. Hausnerová, L. Ehrlichová, P. Ovesná, E. Gazárková, J. Chlubnová, K. Matulová, Luboš Minář, Vít Weinberger, Markéta Bednaříková
M. Madrzyk, T. Macháčková, K. Trachtová, T. Catela Ivković, K. Součková, J. Kotouček, J. Mašek, T. Loja, M. Šachlová, O. Slabý
P. Pokorná, D. Al Tukmachi, K. Trachtová, H. Pálová, S. Adamcová, K. Koželková, P. Múdrý, Z. Pavelka, J. Štěrba, O. Slabý
M. Večeřa, L. Radová, F. Siegl, M. Smrčka, R. Jančálek, M. Hermanová, M. Hendrych, L. Křen, J. Šána, O. Slabý
S. Vokurka, M. Ambrožová, O. Ngo, V. Vaněček, O. Fiala, M. Votavová, O. Hes, J. Presl, J. Ferda, J. Fínek
Clinical Oncology
2022 Issue Supplementum 1
Most read in this issue
- Pilot analysis of the PD-L1 expression in ovarian cancer patients treated with platinum-based chemotherapy
- Retrospective study of patients with tubo-ovarian cancers (n = 510) and an analysis of main factors influencing PFS and OS – the experience of a comprehensive oncology center during 2010–2019
- Sequencing of long non-coding RNAs in exosomes of colorectal cancer patients
- MicroRNAs as potential prognostic and predictive biomarkers in patients with atypical meningioma